RENO, Nev., March 1, 2005 (PRIMEZONE) -- Anywhere MD, Inc. (Pink Sheets:ANWM) announced today that it had entered into a funding agreement with North American Funding, Inc., a Texas-based firm, to sell approximately 1,300,000 shares of its restricted common stock at a purchase price of $0.15 per share in a private placement, for total proceeds of $195,000. The Company will use the funds for working capital needs and expansion. As part of the transaction, the company has agreed to an option to sell up to an additional $805,000 worth of its restricted common stock to this investor at a 10% discount to the market price of the shares at the time of purchase by the investor. The purchaser's right to purchase the additional shares expires six months after the date of closing of the initial private placement.
About Anywhere MD - www.anywheremd.com
Anywhere MD Inc. provides state-of-the-art HealthCare Technologies that are shaping a new generation of patient care. Anywhere MD's expertise in clinical documentation for physicians offers a broad range of technology products to improve productivity for healthcare providers and enable them to diagnose, treat and manage patient information at the highest level.
Anywhere MD Inc. develops, markets, sells and supports proprietary software applications for mobile handheld devices. These mobile applications provide the physician with the most recent and accurate healthcare information at the "Point Of Care." This technology eliminates a confusing and tedious 'paper trail' that can lead to inaccurate and inadequate patient charting, resulting in malpractice suits and poor patient care.
AMD is headquartered on the central coast of California and is committed to serving thousands of healthcare professionals across the USA, Canada, Europe, Asia and Australia.
Except for historical matter contained herein, matters discussed in this news release are forward-looking statements and are made pursuant to the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect assumptions and involve risk and uncertainties, which may affect the Company's business and prospects and cause actual results to differ materially from these forward-looking statements.